Inventor · disambiguated record
Zhao-Kui Wan
Also filed as: WAN ZHAO-KUI
17 granted patents·12 pending applications·78 citations·filing 2005–2022
91Inventor score
Files withJANSSEN PHARMACEUTICA NV9PFIZER9WYETH CORP6JANSSEN SCIENCES IRELAND UNLIMITED CO3XIANG JASON SHAOYUN1
Top patents by PatentIndex Score
29 records- 0195US9663526B2Aminopyrimidinyl compoundsPFIZER·Filed 2015·Granted May 30, 2017·22 cites·26 claims
- 0292US11197867B2Aminopyrimidinyl compoundsPFIZER·Filed 2020·Granted Dec 14, 2021·2 cites·9 claims
- 0389US7521473B2Inhibitors of protein tyrosine phosphatase 1BWYETH CORP·Filed 2005·Granted Apr 21, 2009·23 cites·59 claims
- 0488US7632838B211-beta HSD1 inhibitorsWYETH CORP·Filed 2007·Granted Dec 15, 2009·17 cites·69 claims
- 0586US10463675B2Aminopyrimidinyl compoundsPFIZER·Filed 2017·Granted Nov 5, 2019·4 cites·2 claims
- 0685US10980815B2Aminopyrimidinyl compoundsPFIZER·Filed 2019·Granted Apr 20, 2021·2 cites·8 claims
- 0783US11396517B1Exo-aza spiro inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 26, 2022·6 cites·13 claims
- 0881US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
- 0974US2021377495A1Aminopyrimidinyl compoundsPFIZER·Filed 2021·Application pending·0 cites
- 1068US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
- 1167US2022340598A1Pyrazolopyridinone compoundsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1266US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
- 1361US2009048286A1Inhibitors of Protein Tyrosine Phosphatase 1BWYETH CORP·Filed 2008·Application pending·0 cites
- 1460US11384099B2Pyrazolopyridinone compoundsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 12, 2022·0 cites·27 claims
- 1559US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 1657US2010029648A111-Beta HSD1 InhibitorsXIANG JASON SHAOYUN·Filed 2009·Application pending·0 cites
- 1757US2023039917A1Exo-aza spiro inhibitors of menin-mll interactionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1855US12398155B2Thienopyridinone compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 26, 2025·0 cites·30 claims
- 1953US11053235B2Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Jul 6, 2021·0 cites·17 claims
- 2052US2022348571A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Application pending·0 cites
- 2151US2021220356A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Application pending·0 cites
- 2251US2005203081A1Inhibitors of protein tyrosine phosphatase 1BFiled 2005·Application pending·0 cites
- 2351US2009291971A1Heteroaryl ethers and processes for their preparationWYETH CORP·Filed 2008·Application pending·0 cites
- 2449US10654837B2Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosisJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 19, 2020·0 cites·12 claims
- 2549US2008004325A1PTP1B inhibitorsWYETH CORP·Filed 2007·Application pending·0 cites
- 2648US11639350B2Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infectionsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 2, 2023·0 cites·23 claims
- 2745US11691970B2Pyrazolopyridinone compoundsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 4, 2023·0 cites·45 claims
- 2844US11384075B2Quinolinone compoundsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 12, 2022·0 cites·23 claims
- 2941US7674822B2PTP1b inhibitorsWYETH CORP·Filed 2005·Granted Mar 9, 2010·0 cites·65 claims
Join the waitlist — get patent alerts
Get an alert when Zhao-Kui Wan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →